×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [122]
内容类型
期刊论文 [108]
会议论文 [14]
发表日期
2019 [18]
2018 [13]
2017 [17]
2016 [10]
2015 [22]
2014 [10]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共122条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Efficacy and safety of Run Zao Zhi Yang capsule on chronic eczema: a multiple-center, randomized, double-blind, placebo-controlled clinical study
期刊论文
2019, 卷号: 30, 期号: 7, 页码: 677-684
作者:
Huang, Dan
;
Chen, Kun
;
Zhang, Fu-Ren
;
Yang, Sen
;
Guo, Qing
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
Traditional Chinese medicine
Run Zao Zhi Yang capsule
chronic eczema
clinical trial
randomization
double-blind
placebo
A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
期刊论文
2019
作者:
Zhang Fengchun
;
Liu Zhichun
;
Jiang Lindi
;
Zhang Hao
;
Zhao Dongbao
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2020/01/03
Febuxostat
Gout
Hyperuricemia
Xanthine oxidase inhibitor
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO
会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:
Zeng, Xiaofeng
;
Wang, Yongfu
;
Jiang, Zhenyu
;
Zhang, Zhuoli
;
He, Lan
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2020/01/03
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
期刊论文
2019
作者:
Xiao Yinglian
;
Zhang Shutian
;
Dai Ning
;
Fei Guijun
;
Goh Khean-Lee
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/01/03
erosive oesophagitis
gastric acid
gastro-oesophageal reflux disease
proton pump inhibition
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
期刊论文
2019, 卷号: 157, 期号: 2, 页码: 403-+
作者:
Moayyedi, Paul
;
Eikelboom, John W.
;
Bosch, Jackie
;
Connolly, Stuart J.
;
Dyal, Leanne
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2020/01/03
Heart Disease Prevention
Thrombosis
Stomach
Drug
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO
期刊论文
2019, 卷号: 78, 页码: 1140-1140
作者:
Zeng, Xiaofeng
;
Wang, Yongfu
;
Jiang, Zhenyu
;
Zhang, Zhuoli
;
He, Lan
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL
会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:
Su, Jinmei
;
Li Mengtao
;
Zeng, Xiaofeng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL
期刊论文
2019, 卷号: 78, 页码: 894-894
作者:
Su, Jinmei
;
Li Mengtao
;
Zeng, Xiaofeng
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
Clinical utility of basophil activation test in diagnosis and predicting severity of mugwort pollen-related peach allergy
期刊论文
2019, 卷号: 12, 期号: 6, 页码: 100043
作者:
Deng Shan
;
Yin Jia
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
AUC
area under the curve
BAT
basophil activation test
Basophil activation test
DBPCFC
double-blind placebo-controlled food challenge
LTP
lipid transfer protein
Mugwort pollen allergy
OAS
oral allergy syndrome
Peach allergy
Peach extract
Pru p 3
ROC
receiver operating characteristic
SABA
short-acting β2-agonist
SPT
skin prick testing
SR
systemic reaction
sIgE
specific IgE
Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial
期刊论文
2019, 卷号: 11, 期号: 1, 页码: e12344
作者:
Wang, XuYi
;
Jiang, Haifeng
;
Zhao, Min
;
Li, Jing
;
Gray, Frank
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
buprenorphine-naloxone
opiate dependence
opiate substitution treatment
People's Republic of China
treatment efficacy
©版权所有 ©2017 CSpace - Powered by
CSpace